CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

COGTCogent Biosciences, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $32.02 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$5.56B
RECENT INSIDER TRADES
  • 2026-08-31 · Morris Arlene (Director) · SELL
  • 2026-05-21 · Robbins Andrew R (President and CEO) · OTHER
  • 2026-03-31 · Fairmount Funds Management LLC (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders340
Shares held233,732,658
Value$7.88B
Percent of shares outstanding134.70%
As of quarter end2026-06-30
RECENT NEWS
  • Cogent Biosciences receives FDA acceptance of NDA for Bezuclastinib
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Cogent Biosciences, Inc. (COGT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit